ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$56,000
-96.0%
18,200
-95.7%
0.00%
-100.0%
Q1 2019$1,407,000
-12.8%
420,130
-30.7%
0.00%
-25.0%
Q4 2018$1,613,000
-66.8%
606,295
-30.1%
0.00%
-63.6%
Q3 2018$4,860,000
-5.8%
867,855
-14.7%
0.01%
-15.4%
Q2 2018$5,161,000
-26.5%
1,017,890
-1.2%
0.01%
-18.8%
Q1 2018$7,023,000
+108.4%
1,029,798
+130.7%
0.02%
+100.0%
Q4 2017$3,370,000446,3710.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders